Document is current

Article History

Received: 2 June 2023

Accepted: 28 October 2023

First Online: 15 December 2023

Change Date: 29 December 2023

Change Type: Update

Change Details: The Open Access funding by Projekt DEAL was not included in the original publication, this article has been updated.

Declarations

:

: Local ethics approval was not required at the time for the compassionate use program for pemigatinib. The patient provided informed written consent for the compassionate use program for pemigatinib.

: Written informed consent was obtained from the patient’s next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The authors have no relevant financial or non-financial interests to disclose.